Abstract
The pharmacokinetics of mezlocillin were examined in 8 patients with normal renal function (inulin clearance, > 80 ml/min per 1.73 m2), 32 patients with moderately reduced renal function (inulin clearances, 80 to 5 ml/min per 1.73 m2), and 12 patients maintained by hemodialysis or peritoneal dialysis because of severely impaired renal function. A single dose of 60 mg of mezlocillin per kg of body weight was infused intravenously over 30 min. Antibiotic concentrations in plasma, urine, and dialysate were determined by the agar diffusion technique. The half-life of mezlocillin increased with decreasing renal function from an average of 53 min in subjects with normal function to 165 min in oligoanuric patients. The urinary recovery of this drug in 24 h decreased from 65% at a glomerular filtration rate of 92 ml/min to 7.6% at a glomerular filtration rate of 6.7 ml/min. Volume of distribution was not changed by the renal insufficiency, amounting on the average to 22.5% of body weight. Intermittent hemodialysis or peritoneal dialysis contributed to only a minor degree to the 24-h mezlocillin kinetics. The pharmacokinetic properties of mezlocillin permit a normal dosage over wide ranges of renal insufficiency; however, when the glomerular filtration rate is below 10 ml/min, the dosage interval should be increased from 8 to 12 h.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bergan T., Brodwall E. K., Wiik-Larsen E. Mezlocillin pharmacokinetics in patients with normal and impaired renal functions. Antimicrob Agents Chemother. 1979 Nov;16(5):651–654. doi: 10.1128/aac.16.5.651. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bergan T. Pharmacokinetics of mezlocillin in healthy volunteers. Antimicrob Agents Chemother. 1978 Dec;14(6):801–806. doi: 10.1128/aac.14.6.801. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bodey G. P., Rodriguez V., Stewart D. Clinical pharmacological studies of carbenicillin. Am J Med Sci. 1969 Mar;257(3):185–190. doi: 10.1097/00000441-196903000-00005. [DOI] [PubMed] [Google Scholar]
- Coles G. A. Body composition in chronic renal failure. Q J Med. 1972 Jan;41(161):25–47. [PubMed] [Google Scholar]
- Eastwood J. B., Curtis J. R. Carbenicillin administration in patients with severe renal failure. Br Med J. 1968 Feb 24;1(5590):486–487. doi: 10.1136/bmj.1.5590.486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fiegel P., Becker K. Pharmacokinetics of azlocillin in persons with normal and impaired renal functions. Antimicrob Agents Chemother. 1978 Sep;14(3):288–291. doi: 10.1128/aac.14.3.288. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hoffman T. A., Cestero R., Bullock W. E. Pharmacodynamics of carbenicillin in hepatic and renal failure. Ann Intern Med. 1970 Aug;73(2):173–178. doi: 10.7326/0003-4819-73-2-173. [DOI] [PubMed] [Google Scholar]
- Jusko W. J., Lewis G. P., Schmitt G. W. Ampicillin and hetacillin pharmacokinetics in normal and anephric subjects. Clin Pharmacol Ther. 1973 Jan-Feb;14(1):90–99. doi: 10.1002/cpt197314190. [DOI] [PubMed] [Google Scholar]
- Kunin C. M., Finkelberg Z. Oral cephalexin and ampicillin: antimicrobial activity, recovery in urine, and persistence in blood of uremic patients. Ann Intern Med. 1970 Mar;72(3):349–356. doi: 10.7326/0003-4819-72-3-349. [DOI] [PubMed] [Google Scholar]
- Lode H., Niestrath U., Koeppe P., Langmaack H. Azlocillin und Mezlocillin: Zwei neue semisynthetische Acylureidopenicilline. Infection. 1977;5(3):163–169. doi: 10.1007/BF01639753. [DOI] [PubMed] [Google Scholar]
- Pancoast S. J., Neu H. C. Kinetics of mezlocillin and carbenicillin. Clin Pharmacol Ther. 1978 Jul;24(1):108–116. doi: 10.1002/cpt1978241108. [DOI] [PubMed] [Google Scholar]
- Reidenberg M. M. The binding of drugs to plasma proteins and the interpretation of measurements of plasma concentrations of drugs in patients with poor renal function. Am J Med. 1977 Apr;62(4):466–470. doi: 10.1016/0002-9343(77)90398-9. [DOI] [PubMed] [Google Scholar]
- Ruedy J. The effects of peritoneal dialysis on the physiological disposition of oxacillin, ampicillin and tetracycline in patients with renal disease. Can Med Assoc J. 1966 Feb 5;94(6):257–261. [PMC free article] [PubMed] [Google Scholar]
- Schurig R., Kampf D., Becker H., Förster D. Pharmakokinetik von Azlocillin bei Niereninsuffizienz und Hämodialyse. Arzneimittelforschung. 1979;29(12A):1944–1948. [PubMed] [Google Scholar]